HARBOURVEST PARTNERS LLC Quant / Systematic

CIK: 0001201001 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $181,138 (100.0% shares, 0.0% debt)

Holdings (9)

W Wayfair, Inc. 83.5%

Value ($000) $151,325 Shares 3,843,669 Est. Cost $24.29 Unrealized +66.4%

RRC Range Recources Corp. 5.1%

Value ($000) $9,181 Shares 236,920 Est. Cost $40.45 Unrealized 0.0%

— Finjan Holdings, Inc. 4.0%

Value ($000) $7,331 Shares 4,303,435 Est. Cost $2.70 Unrealized —

— LendingClub Corp. 3.6%

Value ($000) $6,547 Shares 1,059,334 Est. Cost $13.61 Unrealized —

— Sage Therapeutics, Inc. 1.9%

Value ($000) $3,369 Shares 73,168 Est. Cost $53.78 Unrealized —

— Trevena, Inc. 1.2%

Value ($000) $2,104 Shares 311,650 Est. Cost $6.45 Unrealized —

— SolarCity Corporation 0.3%

Value ($000) $565 Shares 28,870 Est. Cost $37.27 Unrealized —

EDIT Editas Medicine 0.3%

Value ($000) $490 Shares 36,362 Est. Cost $20.49 Unrealized 0.0%

— Atara Biotherapeutics, Inc. 0.1%

Value ($000) $226 Shares 10,543 Est. Cost $31.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
W	Wayfair, Inc.	3,843,669	$151,325	83.5%	$24.29	+66.4%	Common	94419L101
RRC	Range Recources Corp.	236,920	$9,181	5.1%	$40.45	0.0%	Common	75281A109
—	Finjan Holdings, Inc.	4,303,435	$7,331	4.0%	$2.70	—	Common	31788H303
—	LendingClub Corp.	1,059,334	$6,547	3.6%	$13.61	—	Common	52603A109
—	Sage Therapeutics, Inc.	73,168	$3,369	1.9%	$53.78	—	Common	78667J108
—	Trevena, Inc.	311,650	$2,104	1.2%	$6.45	—	Common	89532E109
—	SolarCity Corporation	28,870	$565	0.3%	$37.27	—	Common	83416T100
EDIT	Editas Medicine	36,362	$490	0.3%	$20.49	0.0%	Common	28106W103
—	Atara Biotherapeutics, Inc.	10,543	$226	0.1%	$31.40	—	Common	046513107